1. Generics Bulletin

Feedback Sought To Shape Highly Awaited EU Law On Cutting Dependency On Asian Imports

 
• By Neena Brizmohun

Momentum is building around the European Commission’s race to propose a Critical Medicines Act, which aims to tackle drug shortages and create a better framework for establishing manufacturing facilities of essential medicines in the EU.

Open Red Metal Empty Medicine Cabinet Hanging On A Dark Gray Marble Wall Background. Front View
The European Commission is set to propose a major new act to tackle medicine shortages (Shutterstock)

The European Commission is intensifying efforts to fulfil its promise of proposing a Critical Medicines Act in March to tackle drug shortages and reduce the EU’s overreliance on imports from Asia.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Business

Hikma Secures US Rights To Novugen’s Generic Trametinib

 
• By Adam Zamecnik

The move adds another compound with the coveted 180-day exclusivity to Hikma’s portfolio for an undisclosed sum.

Xbrane Approves Deal Giving Away Cimzia Rival To Alvotech

 
• By Adam Zamecnik

After announcing the agreement last month, Xbrane has now approved its deal with Alvotech as part of an extra general meeting.

Samsung Bioepis Reevaluating Approach To Biosimilars

 
• By Jessica Merrill

The challenging US biosimilar market remains a persistent problem, leading the biosimilar developer to reconsider how it invests in the future while pushing for changes.